Fusion of Quantitative Image and Genomic Biomarkers to Improve Prognosis Assessment of Early Stage Lung Cancer Patients
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study aims to develop a new quantitative image feature analysis scheme and investigate its role along with two genomic biomarkers, namely protein expression of the excision repair cross-complementing 1 genes and a regulatory subunit of ribonucleotide reductase (RRM1), in predicting cancer recurrence risk of stage I nonsmall-cell lung cancer (NSCLC) patients after surgery. METHODS: By using chest computed tomography images, we developed a computer-aided detection scheme to segment lung tumors and computed tumor-related image features. After feature selection, we trained a Naïve Bayesian network-based classifier using eight image features and a multilayer perceptron classifier using two genomic biomarkers to predict cancer recurrence risk, respectively. Two classifiers were trained and tested using a dataset with 79 stage I NSCLC cases, a synthetic minority oversampling technique and a leave-one-case-out validation method. A fusion method was also applied to combine prediction scores of two classifiers. RESULTS: Areas under ROC curves (AUC) values are 0.78 ± 0.06 and 0.68 ± 0.07 when using the image feature and genomic biomarker-based classifiers, respectively. AUC value significantly increased to 0.84 ± 0.05 ( ) when fusion of two classifier-generated prediction scores using an equal weighting factor. CONCLUSION: A quantitative image feature-based classifier yielded significantly higher discriminatory power than a genomic biomarker-based classifier in predicting cancer recurrence risk. Fusion of prediction scores generated by the two classifiers further improved prediction performance. SIGNIFICANCE: We demonstrated a new approach that has potential to assist clinicians in more effectively managing stage I NSCLC patients to reduce cancer recurrence risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
Rosell, R., Moran, T., Queralt, C., Porta, R., Cardenal, F., Camps, C., Majem, M., Lopez-Vivanco, G., Isla, D., Provencio, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904554 · Cited by 2,373 · cited 1×
“Since there is no clinical standard for assessing the risk of postsurgery cancer recurrence to date, researchers have explored different genomic biomarkers to identify the molecular fingerprints of different genomic defects in lung cancer development and prognosis [7].”
BackgroundSchrader, J., Gordon-Walker, T. T., Aucott, R. L., van Deemter, M., Quaas, A., Walsh, S., Benten, D., Forbes, S. J., Wells, R. G., & Iredale, J. P. (2011) · Hepatology · doi:10.1002/hep.24108 · Cited by 720
Cited by
Repeatability and Reproducibility of Radiomic Features: A Systematic Review
Traverso, A., Wee, L., Dekker, A., & Gillies, R. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.05.053 · Cited by 903
Beyond imaging: The promise of radiomics
Avanzo, M., Stancanello, J., & El Naqa, I. (2017) · Physica Medica · doi:10.1016/j.ejmp.2017.05.071 · Cited by 483
Radiogenomics: bridging imaging and genomics
Bodalal, Z., Trebeschi, S., Nguyen-Kim, T. D. L., Schats, W., & Beets-Tan, R. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02028-w · Cited by 310
“84) when both data were integrated [115].”
BackgroundFrom Handcrafted to Deep-Learning-Based Cancer Radiomics: Challenges and Opportunities
Afshar, P., Mohammadi, A., Plataniotis, K. N., Oikonomou, A., & Benali, H. (2019) · IEEE Signal Processing Magazine · doi:10.1109/msp.2019.2900993 · Cited by 294
Tracking tumor biology with radiomics: a systematic review utilizing a radiomics quality score
Sanduleanu, S., Woodruff, H. C., de Jong, E. E. C., van Timmeren, J. E., Jochems, A., Dubois, L., & Lambin, P. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.03.033 · Cited by 242
“[25] CT NSCLC Two genomic biomarkers, ERCC1 and RRM1, were evaluated using the selected tumor specimen and a standard IHC-based analytic method 22.”
BackgroundMethodIdentification of non-small cell lung cancer sensitive to systemic cancer therapies using radiomics
Dercle, L., Fronheiser, M., Lu, L., Du, S., Hayes, W., Leung, D. K., Roy, A., Wilkerson, J., Guo, P., Fojo, A. T., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2942 · Cited by 177
Wang, Y., Qiu, Y., Thai, T., Moore, K., Liu, H., & Zheng, B. (2017) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2017.03.017 · Cited by 110
Self-citationCT radiomics to predict high‐risk intraductal papillary mucinous neoplasms of the pancreas
Chakraborty, J., Midya, A., Gazit, L., Attiyeh, M., Langdon‐Embry, L., Allen, P. J., Do, R. K. G., & Simpson, A. L. (2018) · Medical Physics · doi:10.1002/mp.13159 · Cited by 105
Radiogenomics for Precision Medicine With a Big Data Analytics Perspective
Panayides, A. S., Pattichis, M. S., Leandrou, S., Pitris, C., Constantinidou, A., & Pattichis, C. S. (2019) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2018.2879381 · Cited by 66
Cui, S., Tang, T., Su, Q., Wang, Y., Shu, Z., Yang, W., & Gong, X. (2021) · Cancer Imaging · doi:10.1186/s40644-021-00395-6 · Cited by 48
“Radiomics has demonstrated potential utility in oncological imaging in prognosis, detection, and differential diagnosis assessments, such as in the lung [15], breast [16], prostate [17, 18] and liver [19].”
Background
Metadata
- Authors
- Emaminejad, N., Qian, W., Guan, Y., Tan, M., Qiu, Y., Liu, H., & Zheng, B.
- Venue
- IEEE Transactions on Biomedical Engineering
- Published
- 2016-05
- Volume
- 63
- Issue
- 5
- Pages
- 1034-1043
- ISSN
- 0018-9294 (ISSN-L)
- 1558-2531
- OpenAlex
- W2342295631
- Cited by
- 128
- References
- 3
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.